Levofloxacin
Product Images NDC 54868-6277

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Levofloxacin (NDC 54868-6277). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of 250 mg Package Label (6277)

Levofloxacin 250 mg tablets packaging label by Physicians Total Care, Inc. The label indicates 30 tablets per container and includes standard caution about federal law prohibiting dispensing without prescription. The label also lists storage instructions, lot number, expiration date, and a barcode.*

FDA Label Image

Image Of 500 mg Package Label (6278)

Levofloxacin 500 mg tablet bottle label from Physicians Total Care, Inc. The label shows the product name, strength, and dosage form as Levofloxacin tablets, 500 mg, with a package count of 16 tablets. It includes legal and storage information, a barcode, and cautions about dispensing. The label also lists the NDC number 54868-6270-16 and lot and expiration details.*

FDA Label Image

Image Of 750 mg Package Label (6279)

Packaging label for Levofloxacin 750 mg tablets by Physicians Total Care, Inc. The label indicates a package of 10 tablets. It includes dosage warnings, storage instructions, and a barcode, with federal caution about dispensing without prescription.*

FDA Label Image

Figure1 (Figure1)

Chemical structure of the active ingredient Levofloxacin. The diagram shows the molecular arrangement including a fluorine atom, piperazinyl group, ketone, carboxyl group, and a methyl group with stereochemistry indicated. A half molecule of water (1/2 H2O) is also shown as part of the structure.*

FDA Label Image

Figure2 (Figure2)

Pharmacokinetic curve showing plasma concentration (µg/mL) of Levofloxacin over time (hours) after administration of 750 mg by oral tablet and 750 mg by intravenous infusion (90 minutes). The graph compares plasma concentrations between the two routes across a 36-hour time span.*

FDA Label Image

Figure3 (Figure3)

A plasma concentration versus time graph comparing 500 mg Levofloxacin administered orally (p.o.) as tablets and intravenously (i.v.). The graph shows time in hours on the x-axis and plasma concentration in micrograms per milliliter on the y-axis, illustrating the pharmacokinetic profile over 36 hours for both administration routes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.